Adynxx Inc

ADYX OTCMKTS
2.400
-0.150
-5.88%
Delisted 15:19 08/16 EDT
Open
2.400
Prev Close
2.550
High
2.600
Low
2.400
Volume
3.27K
Avg Vol (3M)
68.46K
52 Week High
19.15
52 Week Low
1.920
% Turnover
0.02%
Market Cap
46.92M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Adynxx Inc ADYX stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Adynxx Inc., formerly Alliqua BioMedical, Inc., is a clinical stage biopharmaceutical company. The Company is focused on development of non-opioid therapeutics for the treatment of pain and inflammatory diseases. Its AYX platform utilizes a proprietary technology of non-opioid, disease-modifying transcription factor decoys. Its pipeline includes brivoligide and AYX2. Brivoligide product candidate is a potent and selective inhibitor of the transcription factor EGR1. Brivoligide is being developed for the prevention of post-surgical pain. AYX2 is a potent inhibitor of Kruppel-like Factors (KLF) six, nine and 15, transcription factors that maintain neuronal and glial activities involved in pain. AYX2 is being developed for the long-term suppression of chronic pain.
MORE >

Recently

Name
Price
%Change